| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/04/2001 | CA2078032C Inflatable member having elastic expansion with limited range |
| 09/04/2001 | CA2021550C Novel tritium marqued compounds, its preparation and application for finding of retinoid nuclear receptors |
| 09/04/2001 | CA1341289C Amide complexes |
| 08/30/2001 | WO2001063291A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma |
| 08/30/2001 | WO2001063290A1 Bcmp-7 as marker for diagnosis of breast cancer |
| 08/30/2001 | WO2001063289A1 Diagnosis of breast cancer using bcmp-11 as marker |
| 08/30/2001 | WO2001063288A1 Diagnosis of breast cancer using bcmp-81 as marker |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062800A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062301A2 Imaging agents for diagnosis of parkinson's disease |
| 08/30/2001 | WO2001062288A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | WO2001062281A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | WO2001062207A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/30/2001 | WO2000044682A9 Biodegradable glass compositions and methods for radiation therapy |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018042 Animal model for detection of vulnerable plaques |
| 08/30/2001 | US20010018041 Lymphomas, leukemia |
| 08/30/2001 | CA2401195A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | CA2400874A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | CA2400669A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma |
| 08/30/2001 | CA2400622A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/30/2001 | CA2399999A1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | CA2399550A1 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/29/2001 | EP1127355A1 Products and methods for brachytherapy |
| 08/29/2001 | EP1126884A2 Radiodense compositions |
| 08/29/2001 | EP1126877A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 08/29/2001 | CN1070226C Gallnut oil and its extraction process and application in pharmacy |
| 08/28/2001 | US6280706 Chelating agents |
| 08/28/2001 | US6280703 Simultaneous multimodal measurement of physiological function |
| 08/28/2001 | CA2131816C Technetium-99m labeled peptides for imaging inflammation |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001060863A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 08/23/2001 | WO2001060820A2 Matrix metalloproteinase inhibitors and uses thereof |
| 08/23/2001 | WO2001060417A2 Radioactive therapeutic liposomes |
| 08/23/2001 | WO2001060416A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 08/23/2001 | WO2001060365A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/23/2001 | WO2000074727A3 Radiopharmaceuticals and methods for imaging |
| 08/23/2001 | US20010016587 Contrast agents |
| 08/23/2001 | US20010016327 Prevention complexing |
| 08/23/2001 | US20010016326 Prevention complexing |
| 08/23/2001 | CA2405714A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy |
| 08/23/2001 | CA2400197A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/23/2001 | CA2395841A1 Matrix metalloproteinase inhibitors and uses thereof |
| 08/23/2001 | CA2395038A1 Matrix metalloproteinase inhibitors |
| 08/22/2001 | EP1125304A1 Integrated radiation shied |
| 08/22/2001 | EP1124594A1 Implant with cavities containing therapeutic agents |
| 08/22/2001 | EP1124580A1 Enhanced radiation therapy |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | EP0726781B1 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
| 08/22/2001 | CN1309661A Labelled glutamine and lysine analogues |
| 08/21/2001 | US6277586 Used for detecting the presence of autoantibodies to glutamic acid decarboxylaes (gad) in a biological sample |
| 08/21/2001 | US6277356 Somatostatin peptides, use as a radiopharmaceutical, e.g. for radiotherapy of somatostatin receptor tumors, complexed with y90 |
| 08/21/2001 | CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 08/16/2001 | WO2001058458A1 Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| 08/16/2001 | WO2001058434A2 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 08/16/2001 | WO2001010429A3 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 08/16/2001 | WO2001009190A3 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
| 08/16/2001 | WO2000069473A3 Macromolecular carrier for drug and diagnostic agent delivery |
| 08/16/2001 | WO2000063416A3 F18-labeled oxa fatty acids and methods of making and using the same |
| 08/16/2001 | WO1999064046A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors |
| 08/16/2001 | US20010014686 Position emission tomography |
| 08/16/2001 | US20010014325 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 08/16/2001 | EP1123401A1 BIOACTIVE PEPTIDES AND PEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH) AND PARATHYROID HORMONE-RELATED PEPTIDE (PTHrP) |
| 08/16/2001 | EP1123301A1 Chelating agents for radioimmunotherapy |
| 08/16/2001 | CA2400092A1 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents |
| 08/15/2001 | CN1307907A Iodine-125 seed medicine for intervention treatment and its preparation |
| 08/14/2001 | US6274713 Suited to enhance images of selected mammalian organs, tissues, cells, and the like, in vivo, using magnetic resonance imaging, x-ray, gamma scintigraphy, and ct scanning |
| 08/14/2001 | US6274343 Conjugate of delivery vehicle having ability to localize at neoplastic tissue and agent which increases blood supply to tissue; anticarcinogenic/antitumor agents; diagnostic imaging |
| 08/14/2001 | US6274164 Glass fiber chemical delivery system |
| 08/14/2001 | US6274119 Methods for labeling β-amyloid plaques and neurofibrillary tangles |
| 08/14/2001 | US6274118 Localization and therapy of non-prostatic endocrine cancer with agents directed against prostate specific antigen |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | US6274115 Providing micellular particles comprising phospholipid molecules which are stable to leakage in vitro and in vivo; modifying micellular partilces; introducing into blood stream; incorporatingagent for diagnosis or therapy into secnd group |
| 08/09/2001 | WO2000078364A3 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 08/09/2001 | WO2000078361A3 Methods of imaging and targeting tumor vasculature |
| 08/09/2001 | WO2000074729A3 Alpha or beta emitters to fragments in radioimmunotherapy |
| 08/09/2001 | DE10003653A1 Vektorkonstrukte zur gentherapeutisch vermittelten Radioiodtherapie entdifferenzierter und medullärer Schilddrüsen-Karzinome sowie nicht-thyreoidaler Tumore und ihrer Metastasen Vector constructs for gene therapy mediated radioiodine therapy of medullary thyroid carcinoma and dedifferentiated and non-thyroidal tumors and their metastases |
| 08/08/2001 | EP1121378A1 A process for the preparation of a thrombus imaging agent |
| 08/08/2001 | EP1121377A1 Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents |
| 08/08/2001 | EP1121153A1 Site-specific labeling of disulfide-containing targeting vectors |
| 08/08/2001 | CN1307488A Methods for detecting lesions in dense tissue using LHRH antagonists |
| 08/07/2001 | US6271347 Eosinophil eotaxin receptor |
| 08/07/2001 | US6270745 Radioactive transition metal nitride heterocomplex |
| 08/07/2001 | US6270744 Diagnostic agent for angiopathic diseases |
| 08/07/2001 | CA2025607C Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents |
| 08/02/2001 | WO2001055385A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/02/2001 | WO2001054771A2 Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | WO2001054764A2 Bioabsorbable brachytherapy device |
| 08/02/2001 | WO2001054734A2 188re-labelled 5-thio-d-glucose for radionucleotide tumor therapy |
| 08/02/2001 | WO2001054732A1 Antibodies against ctla4 (cd152), conjugates comprising same, and uses thereof |
| 08/02/2001 | WO2001054680A2 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor |
| 08/02/2001 | CA2397643A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof |
| 08/01/2001 | EP1119553A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 08/01/2001 | EP1119371A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 08/01/2001 | EP1119356A1 Radiolabeled neurokinin-1 receptor antagonists |
| 08/01/2001 | EP0820308B1 Conjugate for treating inflammatory diseases |
| 08/01/2001 | EP0760675B1 Compositions comprising dna damaging agents and p53 |